Extremely Rapid and Intense Induction of Apoptosis in Human Eosinophils by Anti-CD30 Antibody Treatment in Vitro

Journal of Immunology

Volumn 172, Issue 4, 2004, Pages 2186-2193

  Matsumoto, Kenji ^a   Terakawa, Maki ^b   Miura, Kenju ^b   Fukuda, Shuhei ^a   Nakajima, Toshiharu ^a   Saito, Hirohisa ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b SUNTORY LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD30 ANTIBODY; CD30 ANTIGEN; CORTICOSTEROID; CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN TYROSINE KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ALLERGY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; EOSINOPHIL; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMOBILIZATION; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0842321788     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.4.2186     Document Type: Article

References (78)

1. Gleich, G. J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422.
2. Wardlaw, A. J., R. Moqbel, and A. B. Kay. 1995. Eosinophils: biology and role in disease. Adv. Immunol. 60:151.
3. Weller, P. F., K. Lim, H. C. Wan, A. M. Dvorak, D. T. Wong, W. W. Cruikshank, H. Kornfeld, and D. M. Center. 1996. Role of the eosinophil in allergic reactions. Eur. Respir. J. 22(Suppl.):109s.
4. Clutterbuck, E. J., E. M. Hirst, and C. J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 73:1504.
5. Sanderson, C. J. 1992. Interleukin-5, eosinophils, and disease. Blood 79:3101.
6. Lopez, A. F., D. J. Williamson, J. R. Gamble, C. G. Begley, J. M. Harlan, S. J. Klebanoff, A. Waltersdorph, G. Wong, S. C. Clark, and M. A. Vadas. 1986. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Invest. 78:1220.
7. Rothenberg, M. E., W. F. Owen, Jr., D. S. Silberstein, J. Woods, R. J. Soberman, K. F. Austen, and R. L. Stevens. 1988. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J. Clin. Invest. 81:1986.
8. Tai, P. C., L. Sun, and C. J. Spry. 1991. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin. Exp. Immunol. 85:312.
9. Silberstein, D. S., K. F. Austen, and W. F. Owen, Jr. 1989. Hemopoietins for eosinophils. Hematology/Oncology Clin. N. A, 3:511.
10. Stern, M., L. Meagher, J. Savill, and C. Haslett. 1992. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 148:3543.
11. Dewson, G., G. M. Walsh, and A. J. Wardlaw. 1999. Expression of Bcl-2 and its homologues in human eosinophils: modulation by interleukin-5. Am. J. Respir. Cell Mol. Biol. 20:720.
12. Wedi, B., U. Raap, H. Lewrick, and A. Kapp. 1998. IL-4-induced apoptosis in peripheral blood eosinophils. J. Allergy Clin. Immunol. 102:1013.
13. Alam, R., P. Forsythe, S. Stafford, and Y. Fukuda. 1994. Transforming growth factor β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J. Exp. Med. 179:1041.
14. Matsumoto, K., R. P. Schleimer, H. Saito, Y. Iikura, and B. S. Bochner. 1995. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437.
15. Walsh, G. M., M. L. Williamson, F. A. Symon, G. B. Willars, and A. J. Wardlaw. 1996. Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood 87:2815.
16. Mauser, P. J., A. M. Pitman, X. Fernandez, S. K. Foran, G. K. R. Adams, W. Kreutner, R. W. Egan, and R. W. Chapman. 1995. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med. 152:467.
17. Tsuyuki, S., C. Bertrand, R. Erard, A. Trifilieff, J. Tsuyuki, M. Wesp, G. P. Anderson, and A. J. Coyle. 1995. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J. Clin. Invest. 96:2924.
18. Dürkop, H., U. Latza, M. Hummel, F. Eitelbach, B. Seed, and H. Stein. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421.
19. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3:609.
20. Naismith, J. H., and S. R. Sprang. 1998. Modularity in the TNF-receptor family, Trends Biochem. Sci. 23:74.
21. Horie, R., and T. Watanabe. 1998. CD30: expression and function in health and disease. Semin. Immunol. 10:457.
22. Amakawa, R., A. Hakem, T. M. Kundig, T. Matsuyama, J. J. Simard, E. Timms, A. Wakeham, H. W. Mittruecker, H. Griesser, H. Takimoto, et al. 1996. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551.
23. Kurts, C., F. R. Carbone, M. F. Krummel, K. M. Koch, J. F. Miller, and W. R. Heath. 1999. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature 398:341.
24. DeYoung, A. L., O. Duramad, and A. Winoto. 2000. The TNF receptor family member CD30 is not essential for negative selection. J. Immunol. 165:6170.
25. Jung, W., S. Krueger, C. Renner, A. Gause, U. Sahin, L. Trumper, and M. Pfreundschuh. 1994. Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources. Mol. Immunol. 31:1329.
26. Mir, S. S., B. W. Richter, and C. S. Duckett. 2000. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells. Blood 96:4307.
27. Masuda, M., C. Ishida, Y. Arai, T. Okamura, M. Ohsawa, M. Shimakage, and H. Mizoguchi. 1998. Dual action of CD30 antigen: anti-CD30 antibody induced apoptosis and interleukin-8 secretion in Ki-1 lymphoma cells. Int. J. Hematol. 67:257.
28. Romagnani, S., P. Parronchi, M. M. D'Elios, P. Romagnani, F. Annunziato, M. P. Piccinni, R. Manetti, S. Sampognaro, C. Mavilia, M. De Carli, et al. 1997. An update on human Th1 and Th2 cells. Int. Arch. Allergy Immunol. 113:153.
29. Petkova, D., A. Xaubet, C. Picado, X. Filella, C. Agusti, P. Luburich, and R. Rodriguez-Roisin. 2000. Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases. Respir. Med. 94:345.
30. + T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy 55:1011.
31. Vukmanovic-Stejic, M., B. Vyas, P. Gorak-Stolinska, A. Noble, and D. M. Kemeny. 2000. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood 95:231.
32. Telford, W. G., S. Y. Nam, E. R. Podack, and R. A. Miller. 1997. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals. Cell. Immunol. 182:125.
33. Biswas, P., P. Rovere, C. De Filippi, S. Heltai, C. Smith, L. Dagna, G. Poli, A. A. Manfredi, and M. Ferrarini. 2000. Engagement of CD30 shapes the secretion of cytokines by human γδ T cells. Eur. J. Immunol. 30:2172.
34. Cambiaggi, A., C. Cantoni, S. Marciano, T. D. De, S. Pileri, P. L. Tazzari, H. Stein, and S. Ferrini. 1993. Cultured human NK cells express the Ki-1/CD30 antigen. Br. J. Haematol. 85:270.
35. Meerloo, T., H. K. Parmentier, A. D. Osterhaus, J. Goudsmit, and H. J. Schuurman. 1992. Modulation of cell surface molecules during HIV-1 infection of H9 cells: an immunoelectron microscopic study. AIDS 6:1105.
36. Boiocchi, M., V. De Re, A. Gloghini, E. Vaccher, R. Dolcetti, A. Marzotto, G. Bertola, and A. Carbone. 1993. High incidence of monoclonal EBV episomes in Hodgkin's disease and anaplastic large-cell KI-1-positive lymphomas in HIV-1-positive patients. Int. J. Cancer 54:53.
37. + tumors. J. Clin. Oncol. 15:3355.
38. Pizzolo, G., F. Vinante, L. Morosato, G. Nadali, M. Chilosi, G. Gandini, A. Sinicco, R. Raiteri, G. Semenzato, H. Stein, et al. 1994. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 8:741.
39. + T cell involvement in the inflamed joints. Clin. Exp. Immunol. 102:547.
40. Barbano, G., F. Cappa, I. Prigione, V. Pistoia, A. Cohen, S. Chiesa, R. Gusmano, and F. Perfumo. 2001. Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone. Nephrol. Dial. Transplant. 16:1807.
41. Bengtsson, A., L. Holm, O. Back, J. Fransson, and A. Scheynius. 1997. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Clin. Exp. Immunol. 109:533.
42. Caproni, M., E. Salvatore, C. Cardinali, B. Brazzini, and P. Fabbri. 2000. Soluble CD30 and cyclosporine in severe atopic dermatitis. Int. Arch. Allergy Immunol. 121:324.
43. Latza, U., S. Davis, D. Wilhelm, B. McKnight, M. Seyfarth, and H. Stein. 1999. Soluble cytokine receptor CD30 in atopic disorders: a case-control study. Clin. Exp. Allergy. 29:97.
44. De Pita, O., A. Frezzolini, G. Cianchini, M. Ruffelli, P. Teofoli, and P. Puddu. 1997. T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30). Arch. Dermatol. Res. 289:667.
45. Yazawa, N., H. Ihn, K. Yamane, M. Kubo, M. Fujimoto, K. Kikuchi, Y. Soma, and K. Tamaki. 2001. Elevated circulating soluble CD30 levels in patients with polymyositis/dermatomyositis. Br. J. Dermatol. 145:676.
46. Kilwinski, J., T. Berger, J. Mpalaskas, S. Reuter, W. Flick, and P. Kern. 1999. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease. Clin. Exp. Immunol. 115:114.
47. Pinto, A., D. Aldinucci, A. Gloghini, V. Zagonel, M. Degan, S. Improta, S. Juzbasic, M. Todesco, V. Perin, V. Gattei, et al. 1996. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. Blood 88:3299.
48. Pinto, A., D. Aldinucci, A. Gloghini, V. Zagonel, M. Degan, V. Perin, M. Todesco, A. De Iuliis, S. Improta, C. Sacco, et al 1997. The role of eosinophils in the pathobiology of Hodgkin's disease. Ann. Oncol. 8:89.
49. McCluggage, W. G., M. Y. Walsh, and H. Bharucha. 1998. Anaplastic large cell malignant lymphoma with extensive eosinophilic or neutrophilic infiltration. Histopathology 32:110.
50. von Wasielewski, R., S. Seth, J. Franklin, R. Fischer, K. Hubner, M. L. Hansmann, V. Diehl, and A. Georgii. 2000. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood 95:1207.
51. Horn-Lohrens, O., M. Tiemann, H. Lange, J. Kobarg, M. Hafner, H. Hansen, W. Sterry, R. M. Parwaresch, and H. Lemke. 1995. Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4). Int. J. Cancer. 60:539.
52. Hargreaves, P. G., and A. Al-Shamkhani. 2002. Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30. Eur. J. Immunol. 32:163.
53. Hansel, T. T., V. I. De, T. Iff, S. Rihs, M. Wandzilak, S. Betz. K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 145:105.
54. Ebisawa, M., H. Saito, and Y. Iikura. 1990. Platelet-activating factor-induced activation and cytoskeletal change in cultured eosinophils. Int. Arch. Allergy Appl. Immunol. 93:93.
55. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184:39.
56. Gerschenson, L. E., and R. J. Rotello. 1992. Apoptosis: a different type of cell death. FASEB J. 6:2450.
57. Franke, A. C., D. Jung, and T. M. Ellis. 2000. Characterization of the CD30L binding domain on the human CD30 molecule using anti-CD30 antibodies. Hybridoma 19:43.
58. Her, E., J. Frazer, K. F. Austen, and W. F. Owen. 1991. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils: cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell conditioned medium. J. Clin. Invest. 88:1982.
59. Lamas, A. M., G. V. Marcotte, and R. P. Schleimer. 1989. Human endothelial cells prolong eosinophil survival: regulation by cytokines and glucocorticoids. J. Immunol. 142:3978.
60. Lamas, A. M., O. G. Leon, and R. P. Schleimer. 1991. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J. Immunol. 147:254.
61. Wallen, N., H. Kita, D. Weiler, and G. J. Gleich. 1991. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J. Immunol. 147:3490.
62. Schleimer, R. P., and B. S. Bochner. 1994. The effects of glucocorticoids on human eosinophils. J. Allergy Clin. Immunol. 94:1202.
63. Ashkenazi. A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305.
64. Aizawa, S., H. Nakano, T. Ishida, R. Horie, M. Nagai, K. Ito, H. Yagita, K. Okumura, J. Inoue, and T. Watanabe. 1997. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFκB activation. J. Biol. Chem. 272:2042.
65. Duckett, C. S., and C. B. Thompson. 1997. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11:2810.
66. Duckett, C. S., R. W. Gedrich, M. C. Gilfillan, and C. B. Thompson. 1997. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell. Biol. 17:1535.
67. Horie, R., S. Aizawa, M. Nagai, K. Ito, M. Higashihara, T. Ishida, J. Inoue, and T. Watanabe. 1998. A novel domain in the CD30 cytoplasmic tail mediates NFκB activation. Int. Immunol. 10:203.
68. Lee, S. Y., C. G. Park, and Y. Choi. 1996. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183:669.
69. Chiarle, R., A. Podda, G. Prolla, E. R. Podack, G. J. Thorbecke, and G. Inghirami. 1999. CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway. J. Immunol. 163:194.
70. Grell, M., G. Zimmermann, E. Gottfried, C. M. Chen, U. Grunwald, D. C. Huang, Y. H. Wu Lee, H. Durkop, H. Engelmann, P. Scheurich, et al. 1999. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J. 18:3034.
71. Whitcomb, E. A., J. H. Wesolek, and S. H. Pincus. 1989. Modulation of human peripheral blood eosinophil function by tumor necrosis factor-α. Int. Arch. Allergy Appl. Immunol. 89:250.
72. Levi, S. F., V. Temkin, V. Malamud, S. Feld, and Y. Zilberman. 1998. Mast cells enhance eosinophil survival in vitro: role of TNF-α and granulocyte-macrophage colony-stimulating factor. J. Immunol. 160:5554.
73. Suzuki, M., M. Kato, H. Hanaka, T. Izumi, and A. Morikawa. 2003. Actin assembly is a crucial factor for superoxide anion generation from adherent human eosinophils. J. Allergy Clin. Immunol. 112:126.
74. Kita, H., M. Kato, G. J. Gleich, and R. T. Abraham. 1994. Tyrosine phosphorylation and inositol phosphate production: are early events in human eosinophil activation stimulated by immobilized secretory IgA and IgG? J. Allergy Clin. Immunol. 94:1272.
75. Yousefi, S., D. R. Green, K. Blaser, and H. U. Simon. 1994. Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc. Natl. Acad. Sci. USA 91:10868.
76. 4 integrin-mediated adhesion of human eosinophils to fibronectin and vascular cell adhesion molecule-1. J. Allergy Clin. Immunol. 99:648.
77. Samoszuk, M., and L. Nansen. 1990. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 75:13.
78. Poppema, S., M. Potters, L. Visser, and A. M. van den Berg. 1998. Immune escape mechanisms in Hodgkin's disease. Ann. Oncol. 9:S21.